Article
Use of the particle agglutination/particle agglutination-inhibition test for antigenic analysis of SARS-CoV-2
2022-09-09
Abstract excerpt
The antigenicity of SARS-CoV-2 is a critical issue for the effectiveness of the vaccine, and thus it should be phenotypically evaluated by serological assays as new field isolates emerge. The hemagglutination/hemagglutination-inhibition (HA/HI) tests are well-known as a representative method for antigenic analysis of influenza viruses, but SARS-CoV-2 is unlikely to agglutinate to human or guinea pig red blood cell...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bc7d75fc-7e32-555d-9f8a-563f81b00783
- DOI
- 10.1101/2022.09.08.507221
